SPECIAL NOTICE
66 -- Intent to Sole Source for Supply of Adaptive Biotechnologies Kit
- Notice Date
- 8/4/2020 8:13:42 AM
- Notice Type
- Special Notice
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- FDA CENTER FOR DRUG EVALUATION AND RESEARCH Silver Spring MD 20993 USA
- ZIP Code
- 20993
- Solicitation Number
- FDASOLESOURCE1233061
- Response Due
- 8/11/2020 12:00:00 PM
- Archive Date
- 08/26/2020
- Point of Contact
- Howard S. Yablon, Phone: 2404027630
- E-Mail Address
-
howard.yablon@fda.hhs.gov
(howard.yablon@fda.hhs.gov)
- Small Business Set-Aside
- SBA Total Small Business Set-Aside (FAR 19.5)
- Description
- See Attachment for ""Intent to Sole Source"" Notice
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/77ebc0be7dbe4e73973ff590376df5b9/view)
- Place of Performance
- Address: Silver Spring, MD 20993, USA
- Zip Code: 20993
- Country: USA
- Zip Code: 20993
- Record
- SN05744019-F 20200806/200804230145 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |